Onderzoeker
Shana Claeys
- Disciplines:Pediatrie en neonatologie, Moleculaire en celbiologie, Systeembiologie, Verpleegkunde, Genetica
Affiliaties
- Vakgroep Pediatrie en genetica (Departement)
Lid
Vanaf1 okt 2012 → 23 sep 2018
Projecten
1 - 2 of 2
- HBP1 als nieuw therapeutisch doelwit en ALK-MYCN aangedreven neuroblastoomVanaf1 okt 2016 → 30 sep 2017Financiering: VZW en equivalenten
- Functionele studie van de ALK-F1174 mutatie in neuroblastomaVanaf1 okt 2012 → 30 sep 2016Financiering: FWO mandaten, BOF - Andere acties
Publicaties
1 - 10 van 33
- The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness(2020)
Auteurs: Liselot Mus, Irina Lambertz, Shana Claeys, Candy Kumps, Wouter Van Loocke, Christophe Van Neste, Ganesh Umapathy, Marica Vaapil, Christoph Bartenhagen, Genevieve Laureys, et al.
- ALK positively regulates MYCN activity through repression of HBP1 expression(2019)
Auteurs: Shana Claeys, Geertrui Denecker, Kaat Durinck, Bieke Decaesteker, Liselot Mus, Siebe Loontiens, Suzanne Vanhauwaert, Kristina Althoff, Caroline Wigerup, Daniel Bexell, et al.
Pagina's: 2690 - 2705 - The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma(2018)
Auteurs: Bieke Decaesteker, Geertrui Denecker, Wouter Van Loocke, Moritz Gartlgruber, Pauline Depuydt, Fanny De Vloed, Shana Claeys, Dries Rombaut, Anton Henssen, Daniel Dreidax, et al.
Aantal pagina's: 1 - TBX2 is implicated in cell cycle control and proliferation in neuroblastoma(2018)
Auteurs: Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste, Fanny De Vloed, Moritz Gartlgruber, Pauline Depuydt, Wouter Van Loocke, Shana Claeys, Dries Rombaut, Anton Henssen, et al.
Aantal pagina's: 1 - A high-throughput 3’ UTR reporter screening identifies microRNA interactomes of cancer genes(2018)
Auteurs: Gert Van Peer, Evelien Mets, Shana Claeys, Ines De Punt, Maté Ongenaert, Pieter Mestdagh
- Identification of novel drug targets downstream of activated ALK in neuroblastoma(2018)
Auteurs: Shana Claeys
- Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma(2018)
Auteurs: Kristina B Emdal, Anna-Kathrine Pedersen, Dorte B Bekker-Jensen, Alicia Lundby, Shana Claeys, Katleen De Preter, Franki Speleman, Chiara Francavilla, Jesper V Olsen
- The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma(2018)
Auteurs: Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste, Fanny De Vloed, Moritz Gartlgruber, Pauline Depuydt, Wouter Van Loocke, Shana Claeys, Dries Rombaut, Anton Henssen, et al.
Aantal pagina's: 1 - The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma(2017)
Auteurs: Bieke Decaesteker, Geertrui Denecker, Wouter Van Loocke, Moritz Gartlgruber, Pauline Depuydt, Fanny De Vloed, Shana Claeys, Dries Rombaut, Anton Henssen, Daniel Dreidax, et al.
Aantal pagina's: 1 - The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma(2017)
Auteurs: Irina Lambertz, Candy Kumps, Shana Claeys, Geertrui Denecker, Wouter Van Loocke, Christophe Van Neste, Jan Koster, Rogier Versteeg, Johannes Schulte
Aantal pagina's: 1